UBE Corporation’s Pharmaceutical Division is a Japan-based pharmaceutical business focused on drug discovery and CDMO services. It leverages UBE’s expertise in organic synthesis and process chemistry to develop and manufacture active pharmaceutical ingredients (APIs), intermediates, and clinical materials for pharmaceutical companies. The division is expanding into advanced areas such as high-potency APIs, nucleic acid therapeutics, and new drug modalities, while strengthening its global pharmaceutical manufacturing capabilities.